{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Toremifene+Citrate", "query": { "intervention": "Toremifene Citrate" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 15, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Toremifene+Citrate&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-12T10:08:09.116Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03238703", "title": "Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "HER2/Neu Negative", "Invasive Breast Carcinoma", "Postmenopausal", "Stage 0 Breast Cancer", "Stage IA Breast Cancer" ], "interventions": [ { "name": "Anastrozole", "type": "DRUG" }, { "name": "Exemestane", "type": "DRUG" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "Letrozole", "type": "DRUG" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Tamoxifen Citrate", "type": "DRUG" }, { "name": "Toremifene Citrate", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Fred Hutchinson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "FEMALE", "summary": "60 Years and older · Female only" }, "enrollment_count": 0, "start_date": "2018-09-01", "completion_date": "2025-03-14", "has_results": false, "last_update_posted_date": "2018-12-27", "last_synced_at": "2026-09-12T10:08:09.116Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT03238703" }, { "nct_id": "NCT00044291", "title": "Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Breast Neoplasms", "Neoplasms, Hormone-dependent" ], "interventions": [ { "name": "atamestane", "type": "DRUG" }, { "name": "toremifene", "type": "DRUG" }, { "name": "letrozole", "type": "DRUG" }, { "name": "aromatase inhibition", "type": "DRUG" }, { "name": "hormone therapy", "type": "PROCEDURE" }, { "name": "endocrine therapy", "type": "PROCEDURE" }, { "name": "antiestrogen therapy", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Intarcia Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 865, "start_date": "2002-06", "completion_date": "2006-01", "has_results": false, "last_update_posted_date": "2015-07-31", "last_synced_at": "2026-09-12T10:08:09.116Z", "location_count": 17, "location_summary": "Lake Havasu City, Arizona • Tucson, Arizona • Greenbrae, California + 14 more", "locations": [ { "city": "Lake Havasu City", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Greenbrae", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Miami Shores", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00044291" }, { "nct_id": "NCT00003865", "title": "Toremifene in Treating Patients With Ovarian Cancer", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Ovarian Cancer" ], "interventions": [ { "name": "toremifene", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "George Washington University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "FEMALE", "summary": "18 Years to 120 Years · Female only" }, "enrollment_count": 0, "start_date": "1999-07-22", "completion_date": "2017-02-22", "has_results": false, "last_update_posted_date": "2017-07-13", "last_synced_at": "2026-09-12T10:08:09.116Z", "location_count": 1, "location_summary": "Washington D.C., District of Columbia", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00003865" }, { "nct_id": "NCT00267553", "title": "Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Breast Neoplasms", "Neoplasms, Hormone-Dependent" ], "interventions": [ { "name": "Atamestane", "type": "DRUG" }, { "name": "toremifene", "type": "DRUG" }, { "name": "letrozole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Intarcia Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 200, "start_date": "2005-11", "completion_date": "2006-06", "has_results": false, "last_update_posted_date": "2007-09-10", "last_synced_at": "2026-09-12T10:08:09.116Z", "location_count": 6, "location_summary": "Greenbrae, California • Saint Joseph, Michigan • Kansas City, Missouri + 3 more", "locations": [ { "city": "Greenbrae", "state": "California" }, { "city": "Saint Joseph", "state": "Michigan" }, { "city": "Kansas City", "state": "Missouri" }, { "city": "Houston", "state": "Texas" }, { "city": "Norfolk", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00267553" }, { "nct_id": "NCT00010322", "title": "Toremifene With or Without Atamestane in Treating Postmenopausal Women With Metastatic Breast Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "atamestane", "type": "DRUG" }, { "name": "toremifene", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Intarcia Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": null, "start_date": "2000-10", "completion_date": "2001-05", "has_results": false, "last_update_posted_date": "2014-03-26", "last_synced_at": "2026-09-12T10:08:09.116Z", "location_count": 1, "location_summary": "Purchase, New York", "locations": [ { "city": "Purchase", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00010322" }, { "nct_id": "NCT00002595", "title": "Toremifene in Treating Patients With Desmoid Tumors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Desmoid Tumor" ], "interventions": [ { "name": "toremifene", "type": "DRUG" }, { "name": "conventional surgery", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Advocate Lutheran General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": null, "sex": "ALL", "summary": "16 Years and older" }, "enrollment_count": 72, "start_date": "1991-07", "completion_date": "2010-09", "has_results": false, "last_update_posted_date": "2013-07-10", "last_synced_at": "2026-09-12T10:08:09.116Z", "location_count": 1, "location_summary": "Park Ridge, Illinois", "locations": [ { "city": "Park Ridge", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00002595" }, { "nct_id": "NCT00097344", "title": "The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Breast Neoplasms", "Neoplasms, Hormone-Dependent" ], "interventions": [ { "name": "Atamestane", "type": "DRUG" }, { "name": "Toremifene", "type": "DRUG" }, { "name": "Letrozole", "type": "DRUG" }, { "name": "Aromatase inhibition", "type": "DRUG" }, { "name": "Estrogen receptor blocker", "type": "DRUG" }, { "name": "Hormone therapy", "type": "PROCEDURE" }, { "name": "Endocrine therapy", "type": "PROCEDURE" }, { "name": "Antiestrogen therapy", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Intarcia Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 842, "start_date": "2004-12", "completion_date": "2006-08", "has_results": false, "last_update_posted_date": "2007-08-23", "last_synced_at": "2026-09-12T10:08:09.116Z", "location_count": 49, "location_summary": "Mobile, Alabama • Tuscon, Arizona • Hot Springs, Arkansas + 46 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Tuscon", "state": "Arizona" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Greenbrae", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00097344" }, { "nct_id": "NCT00129142", "title": "Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Prostate Cancer", "Osteoporosis", "Fractures" ], "interventions": [ { "name": "Toremifene Citrate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GTx", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "MALE", "summary": "50 Years and older · Male only" }, "enrollment_count": 1200, "start_date": "2003-10", "completion_date": "2007-11", "has_results": false, "last_update_posted_date": "2013-11-15", "last_synced_at": "2026-09-12T10:08:09.116Z", "location_count": 136, "location_summary": "Homewood, Alabama • Mobile, Alabama • Little Rock, Arkansas + 117 more", "locations": [ { "city": "Homewood", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Culver City", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00129142" }, { "nct_id": "NCT00020735", "title": "Toremifene Followed by Radical Prostatectomy in Treating Patients With Stage I or Stage II Prostate Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "toremifene", "type": "DRUG" }, { "name": "conventional surgery", "type": "PROCEDURE" }, { "name": "neoadjuvant therapy", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Joel Nelson, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "MALE", "summary": "18 Years to 120 Years · Male only" }, "enrollment_count": 45, "start_date": "2001-04", "completion_date": "2009-06", "has_results": false, "last_update_posted_date": "2015-12-02", "last_synced_at": "2026-09-12T10:08:09.116Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00020735" }, { "nct_id": "NCT05472792", "title": "Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Breast Cancer", "Quality of Life" ], "interventions": [ { "name": "Accelerated Partial Breast Irradiation (APBI)", "type": "RADIATION" }, { "name": "tamoxifen, anastrozole, exemestane, letrozole, fulvestrant, toremifene", "type": "DRUG" } ], "intervention_types": [ "RADIATION", "DRUG" ], "sponsor": "UNC Lineberger Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "FEMALE", "summary": "65 Years and older · Female only" }, "enrollment_count": 90, "start_date": "2022-05-17", "completion_date": "2032-04-15", "has_results": false, "last_update_posted_date": "2026-05-26", "last_synced_at": "2026-09-12T10:08:09.116Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT05472792" } ] }